Investment news

IsoSpec lands funding for platform that identifies unknown molecules at scale

Identifying molecules in minutes, company targets the “95% unknown” molecular space to support development of new disease treatments and biomarkers. Swiss startup IsoSpec Analytics has secured $1.9 million in funding

Regeneron launches five-year $500m biotech fund

Biopharma giant commits $100m annually to Regeneron Ventures as it seeks to ‘fuel promising biotech innovation.’ Yesterday, as we revealed 2023 was another tough year for longevity investment, biotech heavyweight

Longevity investment hits $3.01bn in full-year 2023

Our 2023 report on the state of longevity investment drops today: the numbers, the sectors, the top deals, the key players and the outlook for 2024 Has the longevity industry

NeuroSense raises $4.5 million, partners on biomarkers for neurodegeneration

Biotech seeks exosome-based biomarkers of neurodegenerative disease as it readies for key clinical trials in ALS and Alzheimer’s. Clinical stage biopharma NeuroSense Therapeutics has joined forces with multinational pharmaceutical manufacturing

Founders Forum and Longevity.Technology join forces to accelerate longevity investment

New international event program launches to bring longevity entrepreneurs and investors together. Founders Forum and Longevity.Technology today announced the launch of the Founders Longevity Forum, a premier event series designed

Varda blasts off with $90m to advance space drug manufacturing program

Startup claims drug production in microgravity means biopharma companies can develop unique formulations not possible on Earth. Space manufacturing startup Varda Space Industries has closed a $90 million Series B

EnteroBiotix lands $34m to take microbiome therapeutics into clinical trials

Company advances clinical-stage programs in IBS and liver disease using next-gen intestinal microbiota transfer technology. Microbiome therapeutics company EnteroBiotix has successfully concluded a $34m funding round to support the advancement

Biolinq lands $58m to advance wearable metabolic health technology

Company targets clinical trial of groundbreaking CGM device that detects blood glucose levels just below the surface of the skin. Health tech company Biolinq has secured $58 million in new

Hevolution announces $20 million impact investment to advance promising aging therapies

Foundation leads a $50 million Series A Extension in Aeovian Pharmaceuticals to advance therapies that target mTORC1 biological pathway. Hevolution Foundation today announced an investment of $20 million as the